Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of a Dietary Supplement in Irritable Bowel Syndrome
NCT07039747Phase 2Recruiting
- Sponsor
- Rouen University Hospital
- Start
- Apr 2025
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Phase 2, randomised trial in irritable bowel syndrome (IBS) (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Irritable Bowel Syndrome Severity Scoring System at 8 weeks. Started Apr 2025; status: recruiting.
02
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT07039747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07039747.